Literature DB >> 3012407

Non-N-methyl-D-aspartate receptors mediating synaptic transmission in the avian cochlear nucleus: effects of kynurenic acid, dipicolinic acid and streptomycin.

H Jackson, E F Nemeth, T N Parks.   

Abstract

We have examined the effects of a number of excitatory amino acid antagonists on transmission at the cochlear nerve-nucleus magnocellularis synapse in the chicken. Using an in vitro preparation and bath application of drugs, we studied the effects of kynurenic acid and several related substances, streptomycin and a selective N-methyl-D-aspartate receptor antagonist, DL-alpha-aminosuberate. The last compound had no effect on evoked transmission. Of the various kynurenic acid-related compounds tested, only kynurenic and dipicolinic acid selectively altered responses in nucleus magnocellularis. Quinolinic acid, a kynurenic acid analogue that is structurally akin to dipicolinic acid but which acts selectively at N-methyl-D-aspartate receptors, was without effect. The effect of kynurenic acid was solely inhibitory, completely blocking postsynaptic responses with a potency dependent on the frequency of nerve stimulation. No such frequency dependence was seen with dipicolinic acid although this compound also completely suppressed evoked responses. In addition dipicolinic acid potentiated postsynaptic responses at concentrations only slightly lower than those causing inhibition. Streptomycin inhibited responses in nucleus magnocellularis but this effect seems to result partially from the ability of the drug to inhibit presynaptic calcium influx. Our finding that selective antagonists of N-methyl-D-aspartate receptors were ineffective while antagonists of both receptor types, such as kynurenic and dipicolinic acids, inhibited evoked responses reinforces the conclusion that postsynaptic receptors mediating transmission at this synapse are of the non-N-methyl-D-aspartate type [Nemeth et al. (1983) Neurosci. Lett. 40, 39-44].(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3012407     DOI: 10.1016/0306-4522(85)90054-5

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  7 in total

1.  AMPA receptor-mediated, calcium-dependent CREB phosphorylation in a subpopulation of auditory neurons surviving activity deprivation.

Authors:  L Zirpel; M A Janowiak; C A Veltri; T N Parks
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

2.  Ipsilateral but not contralateral blockade of excitatory amino acid receptors in the caudal ventrolateral medulla inhibits aortic baroreceptor reflex in rats.

Authors:  T Kubo; M Kihara; Y Misu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-01       Impact factor: 3.000

3.  Unilateral blockade of excitatory amino acid receptors in the nucleus tractus solitarii produces an inhibition of baroreflexes in rats.

Authors:  T Kubo; M Kihara
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-03       Impact factor: 3.000

4.  Synaptic activity-induced Ca(2+) signaling in avian cochlear nucleus magnocellularis neurons.

Authors:  Lie-Cheng Wang; Zheng-Quan Tang; Yong Lu
Journal:  Neurosci Res       Date:  2011-11-25       Impact factor: 3.304

5.  CNS site of action and brainstem circuitry responsible for the intravenous effects of nicotine on gastric tone.

Authors:  Manuel Ferreira; Niaz Sahibzada; Min Shi; William Panico; Mark Niedringhaus; Adam Wasserman; Kenneth J Kellar; Joseph Verbalis; Richard A Gillis
Journal:  J Neurosci       Date:  2002-04-01       Impact factor: 6.167

6.  Excitatory amino acid receptors in the caudal ventrolateral medulla mediate a vagal cardiopulmonary reflex in the rat.

Authors:  A J Verberne; P M Beart; W J Louis
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

7.  Excitatory amino acid receptors in the rostral ventrolateral medulla mediate hypertension induced by carotid body chemoreceptor stimulation.

Authors:  M Amano; T Asari; T Kubo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-06       Impact factor: 3.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.